Qube Research & Technologies (QRT)
HTGM

Qube Research & Technologies (QRT)’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,003
Closed -$58K – 2561
2020
Q4 		$58K Sell
1,003
-2,248
-69% -$131K ﹤0.01% 1687
2020
Q3 		$193K Buy
3,251
+2,861
+734% +$256K ﹤0.01% 1405
2020
Q2 		$51K Buy
+390
New +$34.5K ﹤0.01% 1602

Other funds holding HTGM

CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HTGM Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q1 2021, closing a stake of 1,003 shares — an estimated $58K sold.

Qube Research & Technologies (QRT) first reported a position in HTGM in Q2 2020 and held it in 3 quarters. The position peaked at $193K in Q3 2020. 24 funds tracked by Wall St. Rank hold HTGM as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,003 HTG Molecular Diagnostics, Inc. Common Stock shares in Q1 2021, an estimated $58K.
  • Qube Research & Technologies (QRT) first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s HTG Molecular Diagnostics, Inc. Common Stock position peaked at $193K in Q3 2020.
  • 24 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.